Fab’entech is going to install its offices and its proprietary industrial unit on the site of the pharmaceutical company Delpharm located in the Biodistrict of Lyon (France)

Lyon, France–04th January 2018– Fab’entech, a privately-owned biopharmaceutical company specialized in the development and manufacturing of emergency immunotherapies , is pleased to announce that it has signed a letter of intent with the French pharmaceutical company Delpharm, in order to build its proprietary industrial unit and to install its offices and laboratories on Delpharm’s manufacturing site in Lyon.